Israeli Medtech Firm IceCure Gains FDA Approval for Post-Market Breast Cancer Study
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".
FDA
Pulsenmore Wins First U.S. Client Following FDA Clearance
Israeli company Pulsenmore secures its first U.S. client, the Center for Fetal Medicine in Los Angeles, following FDA clearance for its home pregnancy.
Israeli Innovation Targets Severe Heart Condition: Trisol’s Valve Shows Promising U.S. Trial Outcomes
Israeli Trisol Medical's innovative tricuspid valve replacement system shows promising U.S. trial outcomes for severe heart conditions, improving patient.
Aidoc’s Israeli AI Receives FDA Approval to Speed Emergency Care
Aidoc's Israeli AI receives FDA clearance for a multi-condition solution, speeding up emergency care by analyzing over 100 million patient cases and improving.
Israeli MedTech Firm Bendit Wins FDA Approval for Steerable Microcatheter
Israeli MedTech firm Bendit secures FDA approval for its revolutionary Bendit17 Microcatheter, enhancing precision in complex vascular procedures.
Israeli MedTech Firm IceCure Gains Swiss Approval for Cryoablation Cancer Therapy
Israeli MedTech Firm IceCure gains Swiss approval for revolutionary cryoablation cancer therapy, expanding global reach with innovative treatment options.
FDA Approves Israel-Developed Delphi-MD, Creating New Category for Brain Assessment
FDA approves Israel-Developed Delphi-MD, revolutionizing brain assessment with cutting-edge technology from QuantalX Neuroscience.